17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

similar effects within different populations.<br />

Although lifetime physical activity<br />

is desirable, beginning re c re a t i o n a l<br />

physical activity after the menopause<br />

can probably be beneficial for both<br />

weight control and <strong>breast</strong> cancer risk<br />

reduction {1292}.<br />

Fig. 1.07 Age distribution of benign and maligmant <strong>breast</strong> lesions in patients presenting with a discrete<br />

<strong>breast</strong> lump. From Dixon and Sainsbury {707}.<br />

Endogenous hormones<br />

There is overwhelming evidence from<br />

epidemiological studies that sex steroids<br />

( a n d rogens, estrogens, pro g e s t o g e n s )<br />

have an important role in the development<br />

of <strong>breast</strong> tumours. Breast cancer<br />

incidence rates rise more steeply with<br />

age before menopause than after, when<br />

ovarian synthesis of estrogens and progesterone<br />

ceases and ovarian androgen<br />

production gradually diminishes {1447}.<br />

The estrogen excess hypothesis is central,<br />

stipulating that <strong>breast</strong> cancer risk<br />

depends directly on <strong>breast</strong> tissue expos<br />

u re to estrogens. In vitro studies show<br />

i n c reased <strong>breast</strong> cell proliferation and<br />

inhibition of apoptosis. Animal studies<br />

show increased rates of tumour development<br />

when estrogens are administere d .<br />

The risk is higher among postmenopausal<br />

women who have elevated plasma levels<br />

of testosterone and andro s t e n e d i o n e ,<br />

reduced levels of sex horm o n e - b i n d i n g<br />

globulin (SHBG), and increased levels of<br />

o e s t rone, oestradiol, and bioavailable<br />

oestradiol not bound to SHBG.<br />

A second major theory, the estro g e n<br />

plus progestogen hypothesis {255,<br />

1446}, postulates that, compared to<br />

e x p o s u re to estrogens alone (as in postmenopausal<br />

women not using exogenous<br />

hormones), risk of <strong>breast</strong> cancer is<br />

f u rther increased in women who have<br />

elevated plasma and tissue levels of<br />

e s t rogens in combination with pro g e s t o-<br />

gens. This theory is supported by observations<br />

that proliferation of mammary<br />

epithelial cells is increased during the<br />

luteal phase of the menstrual cycle,<br />

c o m p a red to the follicular phase.<br />

Among premenopausal women, several<br />

studies have not shown any clear association<br />

between <strong>breast</strong> cancer risk and<br />

c i rculating levels of androgens, estrogens,<br />

or pro g e s t e rone {255,1183,2448,<br />

2 6 1 3 , 2 9 0 9 } .<br />

A metabolic consequence of excess<br />

body weight and lack of physical activity<br />

is development of insulin re s i s t a n c e .<br />

Elevated insulin levels, may lead to<br />

increased ovarian and/or adrenal synthesis<br />

of sex steroids, particularly of androgens,<br />

and decrease the hepatic synthesis<br />

and circulating levels of SHBG<br />

{1376}. Especially in postmenopausal<br />

women, elevated plasma andro g e n s<br />

lead to increased estrogen formation in<br />

adipose tissue, and hence to increased<br />

levels of oestrone and oestradiol. The<br />

hypothesis that chronic hyperinsulinemia<br />

might explain the observed associations<br />

of <strong>breast</strong> cancer risk with low plasma<br />

SHBG and elevated androgens and<br />

e s t rogens, among postmenopausal<br />

women {1376} has, however, received<br />

only limited support {661,1377}. Insulingrowth<br />

factor-I (IGF-I) and IGF-binding<br />

proteins (IGFBP) appear to be significant<br />

risk predictors {1127,1377}.<br />

F u t u re adult cancer risk is in part set by<br />

conditions of exposure in utero. The preventive<br />

effect of gravidic toxaemia is re c-<br />

ognized {1288} and since the 1950s studies<br />

have incriminated high birth weight as<br />

a risk factor for cancer, in particular of the<br />

b reast {1857}. Similarly, among twins, the<br />

risk of <strong>breast</strong> cancer may be affected by<br />

the type of twinning (dizygotic versus<br />

monozygotic) and sex of the dizygotic<br />

twin {429}. A study of maternal pre g n a n-<br />

cy hormone levels in China and the<br />

United States of America (USA) did not<br />

find, however, the expected higher levels<br />

in the USA but rather the reverse {1676}.<br />

Another important period is adolescence,<br />

w h e re diet may play a role either dire c t l y<br />

or possibly indirectly through a modification<br />

of growth velocity {242}.<br />

Some specific exposures<br />

Only limited data is available on specific<br />

exposures in relation to <strong>breast</strong> cancer.<br />

Long-term follow-up of women exposed<br />

to the Hiroshima or Nagasaki nuclear<br />

explosions indicates an increased risk of<br />

<strong>breast</strong> cancer, in particular for women<br />

exposed around puberty {2938}.<br />

Similarly, exposure as a result of treatment<br />

and surveillance of tuberculosis is<br />

associated with risk {304}. Yet there is little<br />

evidence for a different pattern of risk<br />

as a function of fractionated versus one<br />

time only irradiation {1678}. Systematic<br />

reviews on occupation and <strong>breast</strong> cancer<br />

are few, indicating an increased risk<br />

for selected occupations and specific<br />

chemical and physical exposures. This<br />

data contrasts with the long-held view<br />

that risk of <strong>breast</strong> cancer is related to<br />

social class, with higher risk for execu-<br />

Table 1.01<br />

Frequency of symptoms of women presenting in a<br />

<strong>breast</strong> clinic {288,698}.<br />

Lump 60-70%<br />

Pain 14-18%<br />

Nipple problems 7-9%<br />

Deformity 1%<br />

Inflammation 1%<br />

Family history 3-14%<br />

16 Tumours of the <strong>breast</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!